Peptide Advocate
Back to News

/ Peptide Advocate

October 16, 2026

Not FDA-Approved3/10 · Low

Kisspeptin-10: What the Science Really Says About the “Hormone Master Switch”

Kisspeptin is the hormone that switches on puberty and keeps the reproductive system running, and kisspeptin-10 is its smallest active piece. Here’s what studies show for fertility, low sex drive and testosterone, what’s known about safety, and why it’s still on the FDA’s restricted list.

Kisspeptin-10: What the science really says about the "hormone master switch"

Kisspeptin is a natural hormone that sits at the very top of the body's reproductive system, and kisspeptin-10 is its smallest active piece. Researchers are exploring kisspeptin for fertility treatment and low sex drive, and online it's promoted as a way to raise testosterone. Here's what the science shows, what's still unknown, and why the FDA has restricted it.

Peptide Advocate · Research explainer · Updated October 2026

What it isA 10-amino-acid fragment of kisspeptin, the hormone that switches on the reproductive system2
Why people are excitedIn small human studies, kisspeptin raised reproductive hormones, helped trigger egg maturation in IVF and boosted sexual brain responses4–6
Human evidencePromising but early: small, short studies, mostly from a few university research groups5,6
Legal statusNot FDA-approved. On the FDA's restricted compounding list since 2023, and banned for male athletes1,8

What is kisspeptin-10?

Kisspeptin was first discovered in 1996 in a search for genes that stop cancer from spreading, which is why it was first called "metastin." Researchers later found it does something even more important: it controls puberty and fertility. People and animals whose kisspeptin system doesn't work don't go through normal sexual development.2

The body makes kisspeptin in several lengths. The longest has 54 amino acids, and the shortest active form, kisspeptin-10, has just 10. All of them work by switching on the same receptor in the brain.2

Where kisspeptin sits in the reproductive hormone chain Kisspeptin, made in the hypothalamus, switches on GnRH neurons. GnRH tells the pituitary gland to release LH and FSH. LH and FSH tell the testes or ovaries to make testosterone or estrogen and to produce sperm or mature eggs. The top of the reproductive hormone chain Kisspeptin starts a cascade that runs from the brain to the testes or ovaries Kisspeptin Made in the hypothalamus, a brain region GnRH Released in pulses by nerve cells kisspeptin switches on LH and FSH Released by the pituitary gland into the blood Testes or ovaries Make testosterone or estrogen; sperm or mature eggs Kisspeptin-10 is the shortest piece that still switches on the kisspeptin receptor.
Simplified illustration based on published research.2,3 Illustration: Peptide Advocate.

Why researchers are excited

Because kisspeptin works at the very top of the hormone chain, it nudges the body to make its own reproductive hormones rather than replacing them. That's different from taking testosterone or estrogen directly, and it opens several possibilities:

  • Turning up the body's own testosterone. In healthy men, kisspeptin-10 raised LH, the hormone that tells the testes to make testosterone, and increased how often the brain sent out its natural hormone pulses.3,4
  • Safer IVF. In IVF, the final "trigger" shot that matures eggs can cause ovarian hyperstimulation syndrome (OHSS), a potentially dangerous swelling of the ovaries. Kisspeptin offers a gentler trigger.5
  • Low sexual desire. Kisspeptin also acts on brain areas involved in sexual arousal and attraction.6
  • Diagnosing puberty problems. How a person responds to kisspeptin-10 may help doctors tell different causes of delayed puberty apart.4
Hormone levels in men during a day-long kisspeptin-10 infusion In four healthy men given kisspeptin-10 by continuous infusion for about a day, average LH rose from 5.5 to 20.9 IU/L and testosterone rose from 16.6 to 24.0 nmol/L. Kisspeptin-10 turned up the hormone signal in men Average levels before and during a day-long infusion in 4 healthy men Before During kisspeptin-10 5.5 20.9 LH IU/L, the signal to the testes About 3.8 times higher 16.6 24.0 Testosterone nmol/L About 45% higher
Bars are scaled separately for each hormone. Source: George, University of Edinburgh, 2012.4

What about people?

Kisspeptin has been tested in people more than most peptides in our series, largely by researchers at Imperial College London and the University of Edinburgh. Note that several key studies used the longer form, kisspeptin-54, not kisspeptin-10.

UseWhoWhat happenedBig caveat
Hormone boost
Kisspeptin-10, 2011–2012		Small groups of healthy men and womenLH rose in a dose-dependent way; in men, testosterone rose too3,4Very small groups, given in a hospital by IV
IVF egg trigger
Kisspeptin-54, 2015		60 women at high risk of OHSSEggs matured in 95% of women; 45% had a live birth per embryo transfer; no moderate or severe OHSS5No comparison with standard triggers; longer form of kisspeptin
Low sexual desire, women
2022		32 premenopausal womenBoosted sexual and attraction brain activity; women reported feeling "more sexy"6Single doses; brain scans, not long-term desire
Low sexual desire, men
2023		32 menBoosted sexual brain activity and raised penile rigidity by up to 56% vs. placebo6Single doses in a lab setting
Low sexual desire after menopause
Completed 2025		44 postmenopausal womenResults not yet published7Awaiting results

The researchers behind the libido studies describe them as proof of concept, not an established treatment, and say larger studies are needed.6 No study has tested kisspeptin-10 as a long-term, at-home treatment for low testosterone, the way it's often promoted online.

10amino acids in kisspeptin-10, the shortest active form2
95%of women in an IVF trial had eggs mature after a kisspeptin trigger5
56%maximum increase in penile rigidity vs. placebo in men with low desire6
2023year the FDA placed kisspeptin-10 on its restricted compounding list1

Is kisspeptin-10 safe?

In research settings, kisspeptin has been well tolerated. The Imperial College libido studies recorded no side effects, and no woman in the IVF trial developed moderate or severe OHSS.5,6 But those were short studies with medical supervision. The open questions:

  • Long-term use is unstudied. No published trial has tested months of self-injected kisspeptin-10.
  • FDA concerns. The FDA says compounded kisspeptin-10 may trigger unwanted immune reactions, may have impurity and quality problems, and that it has little or no safety information for the routes people use. It says it can't tell whether the drug would cause harm.1
  • Hormones affect the whole body. Raising reproductive hormones can affect fertility, mood, the prostate and more, and can hide or worsen conditions that need medical care.
  • Product quality. Kisspeptin-10 sold online as "research use only" isn't made to drug standards.
Athletes: The World Anti-Doping Agency's prohibited list specifically names kisspeptin and drugs that act like it among the testosterone-stimulating peptides banned for male athletes, both in and out of competition.8

Where kisspeptin-10 stands with the FDA

Kisspeptin-10 is not FDA-approved. In September 2023, the FDA added it to its "Category 2" list of compounding ingredients that may pose significant safety risks, which means compounding pharmacies shouldn't use it.1 Unlike BPC-157 and a dozen other peptides, it was not removed from that list in April 2026. It's one of only a handful of substances still on it.9

How kisspeptin's status has changed

  1. 1996The kisspeptin gene is discovered while searching for cancer-spread blockers2
  2. 2003Research shows the kisspeptin receptor is essential for normal puberty2
  3. 2011–2015Human studies show kisspeptin boosts reproductive hormones and can trigger egg maturation in IVF4,5
  4. 2022–2023Small trials find kisspeptin boosts sexual brain responses in people with low desire6
  5. September 29, 2023FDA places kisspeptin-10 on its Category 2 restricted compounding list1
  6. April 2026FDA removes 12 peptides from Category 2. Kisspeptin-10 isn't one of them9
  7. July 2026Not on the agenda when FDA advisers review seven other peptides10
  8. October 15, 2026HHS sends an "interim access policy" for certain peptides to the White House. Which peptides it covers hasn't been made public11
  9. NextResults expected from a completed trial in postmenopausal women7

The research is moving, the rules aren't yet. Kisspeptin is being studied seriously by university researchers, but for now it's available only in clinical trials. We'll update this article as the science and the regulations change.

If you're curious about kisspeptin-10

  • Low testosterone? Get a proper diagnosis. Morning blood tests and a doctor's evaluation can uncover treatable causes, and there are approved treatments.
  • Trying to conceive? A fertility specialist can explain your options, including ways to lower the risk of OHSS during IVF.
  • Low sexual desire? It's common and treatable. A doctor or sex therapist can help, and there are FDA-approved options for some people.
  • Interested in kisspeptin itself? Look for clinical trials, the only safe way to try it right now.
  • Skip "research use only" products, and tell your doctor about any peptides or supplements you take.

The bottom line

Kisspeptin is one of the most scientifically interesting hormones discovered in recent decades: the switch that starts puberty and keeps the reproductive system running. Small, well-run studies suggest it could make IVF safer and help people with low sexual desire, and kisspeptin-10 reliably nudges the body to make more of its own hormones. But those studies were short and supervised, and some used a different form of kisspeptin. Long-term, at-home use hasn't been tested. With the FDA still restricting it and anti-doping rules banning it for male athletes, kisspeptin-10 is a promising research tool to watch, not a do-it-yourself testosterone booster.

References

  1. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks; content current as of April 22, 2026. fda.gov
  2. Chianese R, Colledge WH, Fasano S, Meccariello R. Editorial: the multiple facets of kisspeptin activity in biological systems. Front Endocrinol. 2018;9:727. pmc.ncbi.nlm.nih.gov
  3. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011;96(8):E1228–E1236. repository.up.ac.za
  4. George JT. Functional characterisation and translational applications of kisspeptin-10 [doctoral thesis]. University of Edinburgh; 2012. era.ed.ac.uk
  5. Abbara A, Jayasena CN, Christopoulos G, et al. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab. 2015;100(9):3322–3331. academic.oup.com
  6. Imperial College London. Kisspeptin hormone injection could treat low sex drive in women and men; February 3, 2023 (reporting two trials in JAMA Network Open). imperial.ac.uk
  7. ISRCTN registry. Investigating the effects of kisspeptin in postmenopausal women with hypoactive sexual desire disorder (ISRCTN10669888). isrctn.com
  8. German Sport University Cologne, Institute of Biochemistry. S2: peptide hormones, growth factors, related substances and mimetics (WADA Prohibited List). dshs-koeln.de
  9. 503Pharma. FDA pulls 12 peptides from Category 2 list; April 2026. beehiiv.com
  10. U.S. Food and Drug Administration. July 23–24, 2026 meeting of the Pharmacy Compounding Advisory Committee. fda.gov
  11. Associated Press. Trump administration advances plan for peptide drugs favored by RFK Jr. ABC News; October 15, 2026. abcnews.com

This article is for general education and is not medical advice. Kisspeptin-10 is not approved by the FDA to diagnose, treat, cure or prevent any condition, and this article does not recommend using it or provide dosing information. Talk with a licensed healthcare provider before starting any new treatment. Regulatory information is current as of October 16, 2026 and is changing quickly. Charts and illustrations are original works by Peptide Advocate.

Peptides Referenced

Kisspeptin-10

Hormone Modulator

Stimulates GnRH release to support healthy testosterone and reproductive hormone levels.